我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Therapeutic Effects of "Lactic Acid Bacteria Metabolites: LAB Metabolites" for Diabetes Patients in China

Saori Seki, Yoko Onodera, Xu Zhuo, Li Xianchun, Chen Qingping, Cheng Wenli, Aya Tanabe, Yoshihiro Iwahori

Introduction: In this study, we compared LAB metabolites with Yuquan Pill (a traditional Chinese medicine used in diabetic patients) to confirm the efficacy of LAB metabolites alone in diabetes patients.

Methods: Sixty untreated diabetic patients were divided into two groups, and a 3 month interventional clinical trial was conducted using test food with LAB metabolites, and Yuquan Pill as a positive control.

Results: LAB metabolites are shown to statistically significantly improve clinical symptoms, blood glucose levels, and HbA1c levels compared to Yuquan Pill. Both LAB metabolites and Yuquan Pill also statistically significantly improved blood glucose levels and HbA1c compared to pre-administration.

Conclusion: A 3 month administration of LAB metabolites is effective in improving blood glucose levels and HbA1c in untreated diabetic patients.